Anzeige
Mehr »
Mittwoch, 10.09.2025 - Börsentäglich über 12.000 News
Warum diese Aktie jetzt das perfekte Chance-Risiko-Profil für Investoren bietet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CM8 | ISIN: KYG3314S1066 | Ticker-Symbol: 5UD
Frankfurt
09.09.25 | 09:59
0,494 Euro
+0,41 % +0,002
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
FANGZHOU INC Chart 1 Jahr
5-Tage-Chart
FANGZHOU INC 5-Tage-Chart

Aktuelle News zur FANGZHOU Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.09.Fangzhou Inc.: Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research2
27.08.Fangzhou Inc.: Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand297HONG KONG, Aug. 27, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported...
► Artikel lesen
27.08.FANGZHOU JIANKE (06086): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 20253
15.08.FANGZHOU JIANKE (06086): DATE OF BOARD MEETING-
21.07.Fangzhou and Novo Nordisk link on chronic disease management44
21.07.Fangzhou And Novo Nordisk Collaborate To Combat Chronic Diseases45
18.07.Novo Nordisk, Fangzhou Partner to Tackle Chronic Diseases58
18.07.Fangzhou Inc.: Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management411BEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum...
► Artikel lesen
FANGZHOU Aktie jetzt für 0€ handeln
19.06.FANGZHOU JIANKE (06086): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 19, 20251
18.06.FANGZHOU JIANKE (06086): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE1
18.06.FANGZHOU JIANKE (06086): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
18.06.FANGZHOU JIANKE (06086): APPOINTMENT OF MEMBER OF THE NOMINATION COMMITTEE-
27.05.FANGZHOU JIANKE (06086): INVITATION LETTER TO REGISTERED SHAREHOLDERS FOR ONLINE ATTENDANCE AT 2025 ANNUAL GENERAL MEETING1
27.05.FANGZHOU JIANKE (06086): INVITATION LETTER TO NON-REGISTERED HOLDERS FOR ONLINE ATTENDANCE AT 2025 ANNUAL GENERAL MEETING1
27.05.FANGZHOU JIANKE (06086): FORM OF PROXY ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 19, 2025 OR ANY ADJOURNMENT THEREOF-
27.05.FANGZHOU JIANKE (06086): NOTICE OF ANNUAL GENERAL MEETING-
27.05.FANGZHOU JIANKE (06086): PROPOSALS FOR GENERAL MANDATE TO ISSUE SHARES AND REPURCHASE MANDATE TO REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS ...-
06.05.Fangzhou Inc.: Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform278GUANGZHOU, China, May 5, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced the...
► Artikel lesen
24.04.FANGZHOU JIANKE (06086): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS-
24.04.FANGZHOU JIANKE (06086): LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS-
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1